BIRC5 and neoplasm: The most successful survivin targeting agents have been YM155 (Sepantronium bromide) and tetra-O-methyl nordihydroguaiaretic acid (M4N; Terameprecol; EM-1421), with both demonstrating anti-tumour activity in several phase I and II studies22–25.